Page last updated: 2024-10-30

metformin and Asherman Syndrome

metformin has been researched along with Asherman Syndrome in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Asherman Syndrome: A condition with obliterated endometrial cavity causing secondary AMENORRHEA.

Research Excerpts

ExcerptRelevanceReference
"Metformin was injected intraperitoneally after surgery."1.51Metformin Promotes Regeneration of the Injured Endometrium Via Inhibition of Endoplasmic Reticulum Stress-Induced Apoptosis. ( Ansong, E; Lin, HL; Lin, Q; Shen, LE; Wu, XQ; Xu, XX; Zhang, SS, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, XX1
Zhang, SS1
Lin, HL1
Lin, Q1
Shen, LE1
Ansong, E1
Wu, XQ1

Other Studies

1 other study available for metformin and Asherman Syndrome

ArticleYear
Metformin Promotes Regeneration of the Injured Endometrium Via Inhibition of Endoplasmic Reticulum Stress-Induced Apoptosis.
    Reproductive sciences (Thousand Oaks, Calif.), 2019, Volume: 26, Issue:4

    Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Endometrium; Endoplasmic Reticulum S

2019